Lipocine (LPCN) Other Gross PP&E Adjustments (2016 - 2024)
Historic Other Gross PP&E Adjustments for Lipocine (LPCN) over the last 11 years, with Q4 2024 value amounting to $1.4 million.
- Lipocine's Other Gross PP&E Adjustments rose 693.88% to $1.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.4 million, marking a year-over-year increase of 693.88%. This contributed to the annual value of $1.4 million for FY2024, which is 693.88% up from last year.
- Lipocine's Other Gross PP&E Adjustments amounted to $1.4 million in Q4 2024, which was up 693.88% from $1.3 million recorded in Q4 2023.
- Over the past 5 years, Lipocine's Other Gross PP&E Adjustments peaked at $1.4 million during Q4 2024, and registered a low of $94765.0 during Q4 2020.
- Its 5-year average for Other Gross PP&E Adjustments is $1.0 million, with a median of $1.3 million in 2022.
- As far as peak fluctuations go, Lipocine's Other Gross PP&E Adjustments changed by 0.0% in 2020, and later soared by 111488.74% in 2021.
- Over the past 5 years, Lipocine's Other Gross PP&E Adjustments (Quarter) stood at $94765.0 in 2020, then skyrocketed by 1114.89% to $1.2 million in 2021, then increased by 11.62% to $1.3 million in 2022, then increased by 1.02% to $1.3 million in 2023, then grew by 6.94% to $1.4 million in 2024.
- Its last three reported values are $1.4 million in Q4 2024, $1.3 million for Q4 2023, and $1.3 million during Q4 2022.